Answers are grounded in this paper and cite their sources.
The understanding of the clinical features and the pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH) has advanced considerably over the last decade or so. All cases of PNH appear to be associated with aplastic anemia or, occasionally, with another bone marrow failure syndrome, such as myelodysplastic syndrome. This observation led to the development of the theory that, in order to develop PNH, two events are required: (1) the evolution of a hematopoietic clone which is deficient in glycosylphosphatidylinositol (GPI)‐linked proteins by virtue of an acquired mutation of the pig‐a gene; and (2) selection against the normal residual stem cells without selection against the GPI‐deficient clone. There is now overwhelming evidence that this dual pathogenesis theory for the development of PNH is correct, but the mechanism of selection in favor of the PNH clone remains unclear. The advances in the understanding of PNH are described in detail, with an emphasis placed on the implications that these observations have on the treatment and diagnosis of PNH. In addition, the potential implications of these findings on the classification and treatment of other bone marrow failure syndromes are discussed, as well as the lessons learnt in relation to normal hematopoiesis and cell biology.
No takes yet. Share an insight, caveat, or question.
Hillmen et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: